C. Banzi

A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases

I. Zalaudek, G. Argenziano, C. Longo, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice

O. Nanni, A. Brandes, C. Boni, 2008, Journal of chemotherapy.

Epidermal growth factor receptor (EGFR) gene copy number in colorectal adenoma-carcinoma progression.

S. Piana, A. Ciarrocchi, G. Bisagni, 2012, Cancer genetics.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): Updated survival results and final molecular subgroups analyses.

G. Fontanini, L. Boni, G. Tonini, 2015 .

Changes of biological features in breast cancer cells determined by primary chemotherapy

F. Adami, V. Silingardi, M. Criscuolo, 1997, Breast Cancer Research and Treatment.

Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center

C. Longo, G. Pellacani, S. Piana, 2023, Dermatology practical & conceptual.

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer

E. Van Cutsem, J. Tabernero, Tae Won Kim, 2020, JAMA network open.